KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Total Debt (2016 - 2025)

Historic Total Debt for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $41.4 billion.

  • Merck's Total Debt rose 850.49% to $41.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $41.4 billion, marking a year-over-year increase of 850.49%. This contributed to the annual value of $37.1 billion for FY2024, which is 586.51% up from last year.
  • Latest data reveals that Merck reported Total Debt of $41.4 billion as of Q3 2025, which was up 850.49% from $35.4 billion recorded in Q2 2025.
  • Over the past 5 years, Merck's Total Debt peaked at $41.4 billion during Q3 2025, and registered a low of $26.4 billion during Q3 2021.
  • For the 5-year period, Merck's Total Debt averaged around $33.6 billion, with its median value being $34.2 billion (2024).
  • Per our database at Business Quant, Merck's Total Debt plummeted by 1409.92% in 2021 and then soared by 1938.84% in 2022.
  • Over the past 5 years, Merck's Total Debt (Quarter) stood at $33.1 billion in 2021, then decreased by 7.28% to $30.7 billion in 2022, then rose by 14.22% to $35.1 billion in 2023, then rose by 5.87% to $37.1 billion in 2024, then increased by 11.49% to $41.4 billion in 2025.
  • Its Total Debt stands at $41.4 billion for Q3 2025, versus $35.4 billion for Q2 2025 and $34.8 billion for Q1 2025.